Atellica® CH Diazo Direct Bilirubin (D_DBil)
K-Number: K223078 · 2023-06-12
Device Summary
Frequently Asked Questions
What is the Atellica® CH Diazo Direct Bilirubin (D_DBil)?
Atellica® CH Diazo Direct Bilirubin (D_DBil) is a medical device that received FDA 510(k) clearance on 2023-06-12. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K223078.
When was Atellica® CH Diazo Direct Bilirubin (D_DBil) approved by the FDA?
Atellica® CH Diazo Direct Bilirubin (D_DBil) received FDA 510(k) clearance on 2023-06-12, under approval number K223078.
What company makes Atellica® CH Diazo Direct Bilirubin (D_DBil)?
Atellica® CH Diazo Direct Bilirubin (D_DBil) is manufactured by Siemens Healthcare Diagnostics, Inc..
What is the FDA product code for Atellica® CH Diazo Direct Bilirubin (D_DBil)?
The FDA product code for Atellica® CH Diazo Direct Bilirubin (D_DBil) is CIG.
Other Devices by Siemens Healthcare Diagnostics, Inc.
Related Devices (Code: CIG)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.